XML 169 R153.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combination - Schedule of Purchase Price for Acquisition (Details) (Brooklyn ImmunoTherapeutics, LLC) (10-K) - USD ($)
Sep. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Goodwill $ 696,000 $ 667,000
Brooklyn Immunotherapeutics, LLC [Member]        
Cash     250,296  
Restricted cash     86,000  
Prepaid expenses and other current assets     19,998  
Security deposits and other assets     379,331  
Laboratory equipment     69,597  
In process research and development     6,860,000  
Accounts payable and accrued expenses     (4,528,969)  
Loans payable     (410,000)  
Loans payable, related parties     (1,500,000)  
Net fair value assigned to assets acquired and liabilities assumed     1,226,253  
Goodwill $ 2,043,747   2,043,747 $ 2,043,747
Total     $ 3,270,000